Found: 8
Select item for more details and to access through your institution.
Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 2, p. 134, doi. 10.1215/S1152851703000413
- By:
- Publication type:
- Article
Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 11, p. 2706, doi. 10.1002/cncr.22296
- By:
- Publication type:
- Article
Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 7, p. 1478, doi. 10.1002/cncr.21316
- By:
- Publication type:
- Article
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 2, p. 329
- By:
- Publication type:
- Article
Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 5, p. 754, doi. 10.1002/ijc.20472
- By:
- Publication type:
- Article
Novel Human IgG2b/Murine Chimeric Antitenascin Monoclonal Antibody Construct Radiolabeled with <sup>131</sup>I and Administered into the Surgically Created Resection Cavity of Patients with Malignant Glioma: Phase I Trial Results.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 912
- By:
- Publication type:
- Article